Mecwins | Innovating in biotechnology2021-05-14T08:37:35+00:00

Mecwins

Innovating in biotechnology

We think high. We innovate in biotechnology. Together with our in-house expertise, Mecwins applies the latest advancements of Nanotechnology in the Diagnostic field with the mission of helping scientists and physicians to reach the unbelievable. The detection limit achieved with our technology is several order of magnitude better than that achieved in routine clinical practice.

Mecwins

Innovating in biotechnology

We think high. We innovate in biotechnology. Together with our in-house expertise, Mecwins applies the latest advancements of Nanotechnology in the Diagnostic field with the mission of helping scientists and physicians to reach the unbelievable. The detection limit achieved with our technology is several order of magnitude better than that achieved in routine clinical practice.

Teach your family to have an healthy relationship with food.

Learn more about the science behind Mecwins technology

Mecwins uses its own technology based on single molecule digital counting to produce ultrahigh sensitive immunoassays for oncology, cardiovascular, inflammatory and infectious diseases.

By default the volume is deactivated. Please activate it if you wish

Mecwins Technology

INSTRUMENTS

AVAC Analyzer

AVAC Analyzer

AVAC analyzer provides ultra-high sensitivity, several orders of magnitude better than conventional immunoassays, remarkable throughput up to hundreds of samples per shift, multiplexing, best in class CVS and a broad dynamic range.

See Details
Download Brochure

THERAPEUTIC AREAS

Precision science applied to the biology of health & disease

Mecwins uses its own technology based on single molecule digital counting to produce ultrahigh sensitive immunoassays for oncology, cardiovascular, inflammatory and infectious diseases.

Oncology

Oncology

Mecwins technology has the ability to detect oncology biomarkers at ultra-low levels, opening the way to new options for diagnostics and treatment in cancer research.

Cardiology

Cardiology

Detecting cardiac biomarkers at ultra-low levels is fundamental for the future of heart health. Mecwins technology is able to predict adverse cardiovascular events or the development of heart failure.

Infectious Disease

Infectious Disease

The ultra-high sensitivity plays a key role in the infectious diseases (COVID, HIV, hepatitis, etc..) because it accelerated the diagnosis and it allows discriminating symptomatic from asymptomatic patients.

Inmunology

Inmunology

Mecwins technology enables the measurements cytokines biomarkers in serum and plasma with unprecedented sensitivity enabling new discoveries into the role of inflammation in the biology of health and disease.

Neurology

Neurology

Technology can detect neurological biomarkers associated with brain injury and disease, allowing the detection at much earlier stages.

News and Events

Go to Top